PPIAL4D: Peptidylprolyl Isomerase A (Cyclophilin A)-Like 4D

A pseudogene-derived retrocopy with potential roles in cancer and genomic instability, located in a complex chromosomal region.

Gene Information Card

Symbol PPIAL4D
Full Name Peptidylprolyl Isomerase A (Cyclophilin A) Like 4D
Gene Type protein-coding (retrogene/pseudogene-like)
Chromosomal Location 1q21.1 (GRCh38)
NCBI Gene ID 646309 ncbi.nlm.nih.gov/gene/646309
Ensembl ID ENSG00000269335
UniProt ID A0A0A0MRZ8 (predicted)
OMIM ID None assigned
HGNC ID 44544
Aliases PPIAL4, PPIAL4A, PPIAL4C, PPIAL4E, PPIAL4F

Description

PPIAL4D is a member of the peptidylprolyl isomerase A (PPIA) family, located in a segmentally duplicated region on chromosome 1q21.1. It is a retrocopy derived from the PPIA gene, lacking introns and containing a complete open reading frame. Although classified as a protein-coding gene, its expression is low and its protein product has not been experimentally characterized. PPIAL4D is part of a gene cluster that has been implicated in chromosomal rearrangements and copy number variations associated with neurodevelopmental disorders and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) PPIAL4D is located in a region frequently amplified or rearranged in cancer; its overexpression may contribute to tumorigenesis through altered protein folding or interaction with cyclophilin A pathways. COSMIC: copy number gains and overexpression in multiple cancer types; limited functional evidence.
Genomic instability The 1q21.1 region contains low-copy repeats that predispose to non-allelic homologous recombination, leading to microdeletions/duplications; PPIAL4D is within these breakpoint regions. ClinVar: structural variants in this region are associated with disease; PPIAL4D is a marker for the region.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 0.8 Low
Lymph node 0.5 Low
Bone marrow 0.4 Low
Other tissues 0.1-0.3 Very low/not detected
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 1.2 Low expression
HeLa (cervical cancer) 0.9 Low expression
A549 (lung cancer) 0.7 Low expression
HepG2 (liver cancer) 0.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1Val) Missense Rare (MAF <0.01) Potential loss of start codon; effect unknown
c.200C>T (p.Thr67Met) Missense Rare (MAF <0.01) May affect protein stability; not validated
Copy number gain CNV Frequent in cancer Overexpression; may contribute to oncogenesis
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported; predicted start codon loss may reduce translation.

Gain of Function (GOF)

Copy number gains leading to overexpression are observed in cancer, suggesting a potential gain-of-function role.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• peptidyl-prolyl cis-trans isomerase activity • protein folding
• cytoplasm • nucleus

Pathways

Immunophilins and cyclophilins in protein folding
PPIA-mediated signaling (inferred from homology)

Protein Summary

The PPIAL4D protein is predicted to be a cyclophilin-type peptidylprolyl isomerase, similar to PPIA. It contains a PPIase domain that catalyzes the cis-trans isomerization of proline peptide bonds, which is important for protein folding and trafficking. However, its expression is very low and the protein has not been detected in vivo, suggesting it may be a pseudogene or have tissue-specific functions. Its role in cancer is speculative and requires further investigation.

Related Products

Product name Cat.No. Species Gene ID
PPIAL4D Knockout HEK293 Cell Line EDJ-KQ14851 Human 645142 Details Get a Quote
PPIAL4D Knockout HeLa Cell Line EDJ-KQ60582 Human 645142 Details Get a Quote
PPIAL4D Knockout A-549 Cell Line EDJ-KQ69052 Human 645142 Details Get a Quote
PPIAL4D Knockout HCT 116 Cell Line EDJ-KQ77407 Human 645142 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: